Fig. 1From: Genotype-determined EGFR-RTK heterodimerization and its effects on drug resistance in lung Cancer treatment revealed by molecular dynamics simulations(a) Modeled L858R (blue) mutant and wild type (grey) EGFR structures, with the mutation site colored purple. (b) Modeled L858R-T790M (red) mutant and wild type (grey) EGFR structures, with the mutation sites colored purple. (c) WT EGFR-c-Met heterodimer structure (WT EGFR: grey, c- Met: gold)Back to article page